GetTopicDetailResponse(id=56cd85126e, topicName=HBM4003, introduction=HBM4003, content=null, image=null, comments=0, allHits=652, url=https://h5.medsci.cn/topic?id=8512, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=100150, tagList=[TagDto(tagId=100150, tagName=HBM4003)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2265669, encodeId=130e22656697a, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝細(xì)胞癌#</a> <a href='/topic/show?id=333a6802212' target=_blank style='color:#2F92EE;'>#特瑞普利單抗#</a> <a href='/topic/show?id=56cd85126e' target=_blank style='color:#2F92EE;'>#HBM4003#</a>, objectTitle=Clin Cancer Res | Porustobart聯(lián)合特瑞普利單抗作為晚期肝細(xì)胞癌二線治療的I期研究：療效與安全性分析, objectType=article, longId=878140, objectId=ee4c8e814032, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=ee4c8e814032, replyNumber=0, likeNumber=36, createdTime=2025-05-19, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ee4c8e814032, moduleTitle=Clin Cancer Res | Porustobart聯(lián)合特瑞普利單抗作為晚期肝細(xì)胞癌二線治療的I期研究：療效與安全性分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ee4c8e814032)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
